A recent survey indicates that while China is rapidly advancing in clinical drug trials and supply chain management within the biotechnology sector, the United States still maintains a lead in overall quality, commercialization, capital, and talent. Despite China's growing influence, US industry leaders perceive it as a significant competitive threat, with many believing the US lead will not last beyond a decade. The survey also highlighted that the US faces greater concerns regarding funding cuts than competition from China. AI
RANK_REASON Article discusses findings from a survey about the biotech industry, rather than reporting on a new release, significant event, or research paper.
- Biotechnology Innovation Organization
- China
- Cure Innovation Index
- Deerfield Management
- Georgetown University
- Seema Kumar
- US
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
